Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma
Clinical trial NCT05677373 · WITHDRAWN
Trial details
- NCT number
- NCT05677373
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2025-07-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.